• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减毒甲型H1N1流感病毒在老年人中的感染力降低:与血清及局部抗体的相关性

Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.

作者信息

Powers D C, Murphy B R, Fries L F, Adler W H, Clements M L

机构信息

Gerontology Research Education and Clinical Center, Saint Louis Veterans Administration Medical Center, Missouri.

出版信息

J Am Geriatr Soc. 1992 Feb;40(2):163-7. doi: 10.1111/j.1532-5415.1992.tb01938.x.

DOI:10.1111/j.1532-5415.1992.tb01938.x
PMID:1740601
Abstract

OBJECTIVE

To compare young and elderly adults in terms of their immune responses and rates of infection following intranasal vaccination with a live attenuated influenza virus.

DESIGN

Time series, comparing outcomes in young and elderly convenience sample.

METHOD

Retrospective laboratory analysis of serum and nasal wash specimens collected during prior studies in which young or elderly volunteers had been inoculated with cold-adapted influenza A/Kawasaki/86 (H1N1) reassortant virus.

SETTING

Johns Hopkins Center for Immunization Research.

PARTICIPANTS

Healthy young and elderly adults with pre-vaccination serum hemagglutination inhibition (HAI) antibody titers less than or equal to 1:8.

OUTCOME MEASUREMENTS

Antibody responses in serum and nasal washes.

MAIN RESULTS

The proportion of vaccinees who developed any serum or local antibody response was higher in young compared with elderly subjects (20/20 vs 5/14, P less than 0.0005). Resistance to infection with cold-adapted virus correlated with pre-vaccination levels of serum immunoglobulin G (IgG), serum IgA, and nasal wash IgA antibody to whole virus antigen. Age was highly correlated with a lack of response to vaccine by simple regression, but not when data were adjusted for pre-existing antibody levels.

CONCLUSIONS

Cold-adapted reassortant influenza A H1N1 viruses achieve lower rates of infection in elderly than young adults, primarily due to age-related differences in preexisting levels of immunity which may not be reflected by HAI titer.

摘要

目的

比较年轻成年人和老年人在接种减毒活流感病毒鼻内疫苗后的免疫反应和感染率。

设计

时间序列研究,比较年轻和老年便利样本的结果。

方法

对先前研究中收集的血清和鼻腔冲洗液标本进行回顾性实验室分析,在这些研究中,年轻或老年志愿者接种了冷适应甲型流感病毒/川崎/86(H1N1)重配病毒。

地点

约翰霍普金斯免疫研究中心。

参与者

接种疫苗前血清血凝抑制(HAI)抗体滴度小于或等于1:8的健康年轻和老年成年人。

观察指标

血清和鼻腔冲洗液中的抗体反应。

主要结果

与老年受试者相比,年轻受试者中产生任何血清或局部抗体反应的疫苗接种者比例更高(20/20对5/14,P<0.0005)。对冷适应病毒感染的抵抗力与接种疫苗前血清免疫球蛋白G(IgG)、血清IgA和鼻腔冲洗液中针对全病毒抗原的IgA抗体水平相关。通过简单回归分析,年龄与疫苗无反应高度相关,但在对预先存在的抗体水平进行数据调整后则不然。

结论

冷适应重配甲型H1N1流感病毒在老年人中的感染率低于年轻人,主要是由于与年龄相关的预先存在的免疫水平差异,而HAI滴度可能无法反映这种差异。

相似文献

1
Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.减毒甲型H1N1流感病毒在老年人中的感染力降低:与血清及局部抗体的相关性
J Am Geriatr Soc. 1992 Feb;40(2):163-7. doi: 10.1111/j.1532-5415.1992.tb01938.x.
2
Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.接种活甲型流感病毒疫苗或灭活甲型流感病毒疫苗的老年受试者的全身和局部抗体反应
J Clin Microbiol. 1989 Dec;27(12):2666-71. doi: 10.1128/jcm.27.12.2666-2671.1989.
3
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.接种减毒活流感 A 病毒疫苗或灭活流感 A 病毒疫苗的成年人中局部和全身抗体反应的产生及持续情况。
J Clin Microbiol. 1986 Jan;23(1):66-72. doi: 10.1128/jcm.23.1.66-72.1986.
4
Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.评估一种减毒活冷适应季节性 H1N1 流感病毒疫苗在非人灵长类动物中的复制、免疫原性和保护效力。
Vaccine. 2012 Aug 17;30(38):5603-10. doi: 10.1016/j.vaccine.2012.06.088. Epub 2012 Jul 10.
5
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.接种减毒活流感 A 疫苗、灭活流感 A 疫苗的儿童长期全身及分泌型抗体反应的比较
J Med Virol. 1985 Dec;17(4):325-35. doi: 10.1002/jmv.1890170405.
6
In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.在老年人中,减毒活甲型流感病毒疫苗在诱导血清或分泌性抗体或局部免疫记忆方面,并不比灭活病毒疫苗更具优势。
J Clin Microbiol. 1991 Mar;29(3):498-505. doi: 10.1128/jcm.29.3.498-505.1991.
7
The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.单独及联合接种活流感疫苗和灭活流感疫苗后,年轻成年人及老年人的体液免疫反应。
J Clin Virol. 2002 Apr;24(3):193-201. doi: 10.1016/s1386-6532(01)00246-3.
8
Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.慢性病老年患者中冷重组甲型流感疫苗和三价灭活流感病毒疫苗的安全性及血清抗体反应
J Clin Microbiol. 1986 Sep;24(3):336-42. doi: 10.1128/jcm.24.3.336-342.1986.
9
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.冷适应、三价、鼻内接种减毒活流感病毒疫苗诱导的免疫保护相关因素。
J Infect Dis. 2000 Mar;181(3):1133-7. doi: 10.1086/315323.
10
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.血清反应阳性成人中减毒活甲型H1N1和H3N2流感病毒疫苗的使用。
J Clin Microbiol. 1990 Mar;28(3):596-9. doi: 10.1128/jcm.28.3.596-599.1990.

引用本文的文献

1
Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.基于前沿纳米载体的病毒疫苗的系统设计:多领域叙述性综述
Biomedicines. 2021 May 6;9(5):520. doi: 10.3390/biomedicines9050520.
2
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets.鼻内粉末状减毒活流感疫苗具有热稳定性、免疫原性,并且对雪貂的同源攻击具有保护作用。
NPJ Vaccines. 2021 Apr 21;6(1):59. doi: 10.1038/s41541-021-00320-9.
3
[Immunity and antiviral vaccinations. Example: the respiratory mucosa].
[免疫与抗病毒疫苗接种。示例:呼吸道黏膜]
Antibiotiques (Paris). 2007 May;9(2):130-138. doi: 10.1016/S1294-5501(07)88778-4. Epub 2008 Jan 3.
4
Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus.肌肉内免疫接种活流感病毒比接种灭活病毒更具免疫原性,并能提供更好的保护。
Virol J. 2011 May 21;8:251. doi: 10.1186/1743-422X-8-251.
5
Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.幼儿细胞免疫反应与针对培养确诊流感病毒的保护作用之间的相关性。
Clin Vaccine Immunol. 2008 Jul;15(7):1042-53. doi: 10.1128/CVI.00397-07. Epub 2008 Apr 30.
6
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.使用成年志愿者,对以无毒产肠毒素大肠杆菌和新型生物载体作为黏膜佐剂的鼻内三价灭活流感疫苗进行I期评估。
J Virol. 2006 May;80(10):4962-70. doi: 10.1128/JVI.80.10.4962-4970.2006.
7
[Antiviral vaccination and respiratory mucosal immunity: still disappointing results from a seductive idea].[抗病毒疫苗接种与呼吸道黏膜免疫:诱人设想仍带来令人失望的结果]
Presse Med. 2005 Oct 8;34(17):1245-53. doi: 10.1016/s0755-4982(05)84165-x.
8
Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?鼻内冷适应流感病毒疫苗与灭活流感病毒疫苗联合使用:对老年人有额外增强作用?
Drugs Aging. 2004;21(6):349-59. doi: 10.2165/00002512-200421060-00001.
9
Respiratory viral infections in the elderly.老年人的呼吸道病毒感染
Antiviral Res. 1999 Dec 15;44(2):79-102. doi: 10.1016/s0166-3542(99)00062-5.
10
Genetically engineered live attenuated influenza A virus vaccine candidates.基因工程减毒活甲型流感病毒候选疫苗
J Virol. 1997 Apr;71(4):2772-8. doi: 10.1128/JVI.71.4.2772-2778.1997.